Learn more about the MassNextGen sponsors and how your company can join the movement.
If you are interested in sponsoring the MassNextGen Initiative, please reach out to Carla Reimold, Executive Vice President of Scientific Innovation and Strategic Investments at CReimold@masslifesciences.com.
“Early-stage science is critical to unlocking the innovations that support the health of patients and a strong and resilient bench-to-bedside ecosystem here in Massachusetts. Takeda remains a proud and committed sponsor of the MassNextGen program and we’re excited to support this next cohort of visionary entrepreneurs.”
-Julie Kim
President of Takeda’s U.S. Business Unit
and U.S. Country Head
“The Healey -Driscoll administration and MLSC understand the value of fostering an ecosystem that aims to positively influence and advance science for patients around the globe. As a Change sponsor, it is a privilege to support this initiative and provide mentorship to early-stage companies to help grow an ecosystem built for all.”
-Michal Preminger
“Lifesaving technologies start with a Founder and an idea. MLSC’s MassNextGen program empowers a new, diverse group of Founders and prepares them for the challenging road between products and patients. We’re proud to support this program and these talented entrepreneurs.”
-Jon Weaver
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.
